Corrigendum to Diverse chemotypes disrupt ion homeostasis in the malaria parasite, [Mol Microbiol, 2015, 94, 2, 327-339] DOI: 10.1111/mmi.12765.;Diverse chemotypes disrupt ion homeostasis in the malaria parasite

Molecular Microbiology

Volumn 94, Issue 2, 2014, Pages 327-339

  Lehane, Adele M ^a   Ridgway, Melanie C ^a   Baker, Eileen ^a   Kirk, Kiaran ^a  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANTIPARASITIC AGENT; ARTEMISININ; CHLOROQUINE; COMPOUND MMV006656; COMPOUND MMV006764; COMPOUND MMV007275; COMPOUND MMV011567; COMPOUND MMV665826; COMPOUND MMV665949; NITD 609; SPIROINDOLONE DERIVATIVE; UNCLASSIFIED DRUG; ADENOSINE TRIPHOSPHATASE; ANTIMALARIAL AGENT; HYDROGEN; ION; SODIUM;

ANTIMALARIAL ACTIVITY; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG STRUCTURE; GENE; GENE MUTATION; HOMEOSTASIS; MICROBIAL DIVERSITY; NONHUMAN; PFATP4 GENE; PH; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SODIUM TRANSPORT; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; DRUG RESISTANCE; ENZYMOLOGY; METABOLISM;

ADENOSINE TRIPHOSPHATASES; ANTIMALARIALS; DRUG RESISTANCE; HOMEOSTASIS; HYDROGEN; HYDROGEN-ION CONCENTRATION; IONS; PLASMODIUM FALCIPARUM; SODIUM;

EID: 84916599750     PISSN: 0950382X     EISSN: 13652958     Source Type: Journal    
DOI: 10.1111/mmi.13080     Document Type: Erratum

References (32)

1. Adjalley, S.H., Lee, M.C., and Fidock, D.A. (2010) A method for rapid genetic integration into Plasmodium falciparum utilizing mycobacteriophage Bxb1 integrase. Methods Mol Biol 634: 87-100.
2. Allen, R.J., and Kirk, K. (2010) Plasmodium falciparum culture: the benefits of shaking. Mol Biochem Parasitol 169: 63-65.
3. Ashley, E.A., Dhorda, M., Fairhurst, R.M., Amaratunga, C., Lim, P., Suon, S., etal. (2014) Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 371: 411-423.
4. Bowman, J.D., Merino, E.F., Brooks, C.F., Striepen, B., Carlier, P.R., and Cassera, M.B. (2014) Anti-apicoplast and gametocytocidal screening to identify the mechanisms of action of compounds within the Malaria Box. Antimicrob Agents Chemother 58: 811-819.
5. Duffy, S., and Avery, V.M. (2013) Identification of inhibitors of Plasmodium falciparum gametocyte development. Malar J 12: 408.
6. Gamo, F.J., Sanz, L.M., Vidal, J., de Cozar, C., Alvarez, E., Lavandera, J.L., etal. (2010) Thousands of chemical starting points for antimalarial lead identification. Nature 465: 305-310.
7. Gross-Bellard, M., Oudet, P., and Chambon, P. (1973) Isolation of high-molecular-weight DNA from mammalian cells. Eur J Biochem 36: 32-38.
8. Guiguemde, W.A., Shelat, A.A., Bouck, D., Duffy, S., Crowther, G.J., Davis, P.H., etal. (2010) Chemical genetics of Plasmodium falciparum. Nature 465: 311-315.
9. +-ATPase in the parasitic protist, Trypanosoma cruzi. Biochim Biophys Acta 1758: 738-746.
10. 2+-ATPase (PfATP4) belonging to a subclass unique to apicomplexan organisms. J Biol Chem 276: 10782-10787.
11. Lambros, C., and Vanderberg, J.P. (1979) Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol 65: 418-420.
12. Lee, P., Ye, Z., Van Dyke, K., and Kirk, R.G. (1988) X-ray microanalysis of Plasmodium falciparum and infected red blood cells: effects of qinghaosu and chloroquine on potassium, sodium, and phosphorus composition. Am J Trop Med Hyg 39: 157-165.
13. Lucantoni, L., Duffy, S., Adjalley, S.H., Fidock, D.A., and Avery, V.M. (2013) Identification of MMV malaria box inhibitors of Plasmodium falciparum early-stage gametocytes using a luciferase-based high-throughput assay. Antimicrob Agents Chemother 57: 6050-6062.
14. + via sodium ATPase (PpENA1) ensures normal growth of Physcomitrella patens under moderate salt stress. Plant Physiol 144: 1786-1796.
15. Mauritz, J.M., Seear, R., Esposito, A., Kaminski, C.F., Skepper, J.N., Warley, A., etal. (2011) X-ray microanalysis investigation of the changes in Na, K, and hemoglobin concentration in Plasmodium falciparum-infected red blood cells. Biophys J 100: 1438-1445.
16. van Pelt-Koops, J.C., Pett, H.E., Graumans, W., van der Vegte-Bolmer, M., van Gemert, G.J., Rottmann, M., etal. (2012) The spiroindolone drug candidate NITD609 potently inhibits gametocytogenesis and blocks Plasmodium falciparum transmission to Anopheles mosquito vector. Antimicrob Agents Chemother 56: 3544-3548.
17. Pillai, A.D., Addo, R., Sharma, P., Nguitragool, W., Srinivasan, P., and Desai, S.A. (2013) Malaria parasites tolerate a broad range of ionic environments and do not require host cation remodelling. Mol Microbiol 88: 20-34.
18. Plouffe, D., Brinker, A., McNamara, C., Henson, K., Kato, N., Kuhen, K., etal. (2008) In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen. Proc Natl Acad Sci USA 105: 9059-9064.
19. Rottmann, M., McNamara, C., Yeung, B.K., Lee, M.C., Zou, B., Russell, B., etal. (2010) Spiroindolones, a potent compound class for the treatment of malaria. Science 329: 1175-1180.
20. +-ATPase. J Biol Chem 274: 33213-33219.
21. Saliba, K.J., Horner, H.A., and Kirk, K. (1998) Transport and metabolism of the essential vitamin pantothenic acid in human erythrocytes infected with the malaria parasite Plasmodium falciparum. J Biol Chem 273: 10190-10195.
22. van Schalkwyk, D.A., Priebe, W., and Saliba, K.J. (2008) The inhibitory effect of 2-halo derivatives of D-glucose on glycolysis and on the proliferation of the human malaria parasite Plasmodium falciparum. J Pharmacol Exp Ther 327: 511-517.
23. Smilkstein, M., Sriwilaijaroen, N., Kelly, J.X., Wilairat, P., and Riscoe, M. (2004) Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob Agents Chemother 48: 1803-1806.
24. Spangenberg, T., Burrows, J.N., Kowalczyk, P., McDonald, S., Wells, T.N., and Willis, P. (2013) The open access malaria box: a drug discovery catalyst for neglected diseases. PLoS ONE 8: e62906.
25. + regulation in the malaria parasite Plasmodium falciparum involves the cation ATPase PfATP4 and is a target of the spiroindolone antimalarials. Cell Host Microbe 13: 227-237.
26. + extrusion imposes an 'acid load' on the intraerythrocytic malaria parasite. Mol Biochem Parasitol 189: 1-4.
27. Spry, C., Macuamule, C., Lin, Z., Virga, K.G., Lee, R.E., Strauss, E., and Saliba, K.J. (2013) Pantothenamides are potent, on-target inhibitors of Plasmodium falciparum growth when serum pantetheinase is inactivated. PLoS ONE 8: e54974.
28. Strehler, E.E. (2013) Plasma membrane calcium ATPases as novel candidates for therapeutic agent development. J Pharm Pharm Sci 16: 190-206.
29. Trager, W., and Jensen, J.B. (1976) Human malaria parasites in continuous culture. Science 193: 673-675.
30. Treeck, M., Sanders, J.L., Elias, J.E., and Boothroyd, J.C. (2011) The phosphoproteomes of Plasmodium falciparum and Toxoplasma gondii reveal unusual adaptations within and beyond the parasites' boundaries. Cell Host Microbe 10: 410-419.
31. White, N.J., Pukrittayakamee, S., Phyo, A.P., Rueangweerayut, R., Nosten, F., Jittamala, P., etal. (2014) Spiroindolone KAE609 for falciparum and vivax malaria. N Engl J Med 371: 403-410.
32. Wongsrichanalai, C., and Sibley, C.H. (2013) Fighting drug-resistant Plasmodium falciparum: the challenge of artemisinin resistance. Clin Microbiol Infect 19: 908-916.